CCR6 and neoplasm: Inhibition of the STAT3 pathway and CCR6-CCL20 axis prevented Treg infiltration and inhibited tumor growth, thereby enhancing the radiosensitivity of HNSCC, and activating dendritic cells which reduced the growth of tumor cells that were resistant to radiotherapy [91–93].